Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Belgiums Tigenix says heart attack stem cell trial successful

      Belgium's Tigenix says heart attack stem cell trial successful

      supriya kashyap kashyap14 March 2017 10:54 AM IST
      Belgian biotech group Tigenix said its medical trial with a novel treatment for patients at risk of heart failure after a coronary attack was...
      Mylan deal clears path for biosimilar copy of Roches Herceptin

      Mylan deal clears path for biosimilar copy of Roche's Herceptin

      supriya kashyap kashyap14 March 2017 10:53 AM IST
      London : Generic drug maker Mylan said it had reached a settlement with Roche providing "a clear pathway" for the launch of its biosimilar version of...
      FDA approves Novartis drug as first-line treatment for breast cancer

      FDA approves Novartis drug as first-line treatment for breast cancer

      supriya kashyap kashyap14 March 2017 10:53 AM IST
      Novartis AG said that the U.S. Food and Drug Administration had approved the company's experimental drug, kisqali, as a first-line treatment for a...
      US Healthcare Bill:  14 million lose coverage under GOP health bill

      US Healthcare Bill: 14 million lose coverage under GOP health bill

      supriya kashyap kashyap14 March 2017 9:08 AM IST
      Nonpartisan analysts project that 14 million people would lose coverage next year under the House bill dismantling former President Barack Obama's...
      Fujifilm India to install 1,000 Computer Radiography across India to improve healthcare infrastructure

      Fujifilm India to install 1,000 Computer Radiography across India to improve healthcare infrastructure

      supriya kashyap kashyap13 March 2017 12:00 PM IST
      Mumbai : Fujifilm India Private Ltd., a leader in medical equipments and devices to install 1,000 Computer Radiography across India with a commitment...
      Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing

      Glenmark Pharmaceuticals and Evestra, Inc. Announce Partnership Agreement for Generic NuvaRing

      supriya kashyap kashyap13 March 2017 11:21 AM IST
      Mumbai : Glenmark Pharmaceuticals Inc., USA, and Evestra, Inc. have completed a strategic development, license and commercialization agreement to...
      Branded heart, diabetes drugs much costlier than generic ones

      Branded heart, diabetes drugs much costlier than generic ones

      supriya kashyap kashyap13 March 2017 11:18 AM IST
      New Delhi : Leading brands of some of the drugs used for treatment of cardiac diseases and diabetes are up to 10 times higher than generic medicines,...
      MedGenome launches liquid biopsy blood test Oncotrack for cancer detection in patients

      MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

      supriya kashyap kashyap13 March 2017 10:05 AM IST
      Mumbai : MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for...
      Samsung, Karnataka Govt. sign MoU to bolster public healthcare facilities

      Samsung, Karnataka Govt. sign MoU to bolster public healthcare facilities

      supriya kashyap kashyap12 March 2017 11:01 AM IST
      New Delhi : Samsung India announced its partnership with the Government of Karnataka after it signed an MoU to help the state efficiently manage its...
      Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

      Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief

      supriya kashyap kashyap12 March 2017 11:00 AM IST
      Washington : U.S. President Donald Trump has chosen Dr. Scott Gottlieb, a conservative health policy expert with deep ties to the pharmaceutical...
      New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

      New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine

      supriya kashyap kashyap12 March 2017 10:42 AM IST
      Holzkirchen : Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, presented data for its proposed biosimilar adalimumab...
      Dr Reddy’s Visakhapatnam Facility Gets 13 Observations From US Drug Regulator

      Dr Reddy’s Visakhapatnam Facility Gets 13 Observations From US Drug Regulator

      supriya kashyap kashyap12 March 2017 9:18 AM IST
      New Delhi : The U.S. drug regulator has made observations related to deviation from good manufacturing practices at Dr Reddy's Laboratories Ltd.’s...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok